IZO Stock Overview
A research and development company, develops diagnostic products for detecting breast cancers. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Izotropic Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.05 |
| 52 Week High | CA$0.22 |
| 52 Week Low | CA$0.045 |
| Beta | 1.79 |
| 11 Month Change | -16.67% |
| 3 Month Change | -33.33% |
| 1 Year Change | -64.29% |
| 33 Year Change | -94.79% |
| 5 Year Change | -80.00% |
| Change since IPO | -84.85% |
Recent News & Updates
Shareholder Returns
| IZO | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | 0% | -0.4% | 0.8% |
| 1Y | -64.3% | -15.3% | 22.3% |
Return vs Industry: IZO underperformed the Canadian Medical Equipment industry which returned -15.3% over the past year.
Return vs Market: IZO underperformed the Canadian Market which returned 22.3% over the past year.
Price Volatility
| IZO volatility | |
|---|---|
| IZO Average Weekly Movement | 32.4% |
| Medical Equipment Industry Average Movement | 14.8% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: IZO's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: IZO's weekly volatility (32%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | Bob Thast | izocorp.com |
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.
Izotropic Corporation Fundamentals Summary
| IZO fundamental statistics | |
|---|---|
| Market cap | CA$2.84m |
| Earnings (TTM) | -CA$2.35m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.2x
P/E RatioIs IZO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IZO income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$2.35m |
| Earnings | -CA$2.35m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.041 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -46.7% |
How did IZO perform over the long term?
See historical performance and comparison